Acliz 50mg

Tablet
Meclizine Hydrochloride
Aristo pharma

Other Strength:
- Acliz Plus 25mg+50mg

Alternative:
- Meczin 50mg



Acliz
Presentation:
Acliz Tablet: Each chewable tablet contains Meclizine HCl USP 50 mg.

Indications:
Prevention and treatment of nausea, vomiting, motion sickness and vertigo.

Dosage & Administration:
Nausea and vomiting: 25-50 mg once daily.
Motion sickness: Take an initial dose of 25 to 50 mg, 1 hour prior to travel. May repeat dose every 24 hours for
the duration of the journey.Children: Age 6-12 years, 12.5 mg once daily. Age 2-6 years, 6.25 mg once daily.

Contrainidications:
Hypersensitivity to meclizine.
Vertigo: 25 to 100 mg daily in divided doses.
Radiotherapy induced nausea and vomiting: 50 mg two to twelve hours prior to radiotherapy.

Warning & Precautions:
Hazardous tasks: May produce drowsiness; patients should observe caution while driving or performing other tasks requiring alertness.
Because of the anticholinergic action of this agents, use with caution and with appropriate monitoring in patients with glaucoma, obstructive disease of the GI or GU tract, and in elderly males with possible prostatic hypertrophy. These drugs may have a hypotensive action, which may be confusing or dangerous in postoperative patients.
May have additive effects with alcohol and other CNS depressants (eg. hypnotics, sedatives, tranquilizers, antianxiety agent); use with caution.

Side effects:
Cardiovascular: Hypotension; palpitations; tachycardia.
CNS: Drowsiness, restlessness, excitation, nervousness, insomnia, euphoria, blurred vision, diplopia, vertigo, and tinnitus, auditory and visual hallucinations (particularly when dosage recommendations are exceeded.)
Dermatologic: Urticaria, rash
Gastrointestinal: Dry mouth; anorexia, nausea, vomiting, diarrhoea, constipation.
Urinary tract: Urinary frequency, difficult urination, and urinary retention.
Miscellaneous: Dry nose and throat.

Use in special groups:
Use in pregnancy: Category B.Large scale human studies have not demonstrated adverse fatal effects. It has been demonstrated that, based on available data, Meclizine presents the lowest risk of teratogenicity and is the drug of first choice in treating nausea and vomiting during pregnancy.
Use in lactation: Meclizine may be excreated into breast milk. However problem in humans have not been documented.
Use in children: Meclizine can be given to children of 2 and above years of age.

এই পাতাটি ৫৪০ বার দেখা হয়েছে